ライフサイエンスコーパス: technetium 99m

1 gregates of human serum albumin labeled with technetium 99m.

2 icotinamide, annexin V was radiolabeled with technetium 99m.

3 Traditional tracers included technetium 99m ( 99m Tc) sulfur colloid, gallium 67, and

4 e, microsphere blood flow (MBF) testing, and technetium 99m ((99m)Tc) 2 methoxyisobutylisonitrile (MI

5 determine if commonly administered doses of technetium 99m ((99m)Tc) mertiatide (MAG3) in the range

6 ), which promotes in vivo cellular uptake of technetium 99m ((99m)Tc) or iodine 124 ((124)I), as a re

7 sm who underwent preoperative imaging with a technetium 99m ((99m)Tc) sestamibi and (99m)TcO4- protoc

8 nclusive results at ultrasonography (US) and technetium 99m ((99m)Tc) sestamibi scintigraphy.

9 on emission computed tomography (SPECT) with technetium 99m ((99m)Tc) tropane dopamine transporter (T

10 maged owing to internally bound, or trapped, technetium 99m ((99m)Tc)-labeled hSSTr2-binding peptide

11 between the lung elimination rate of inhaled technetium 99m ((99m)Tc)-sestamibi and immunohistochemic

12 iated HIV surrogate) and 18.5-MBq (500-muCi) technetium 99m ((99m)Tc)-sulfur colloid (HIV-sized 100-n

13 We performed intraoperative technetium-99m ((99m)Tc) sentinel lymph node (SN) mappin

14 was to determine the extent to which inhaled technetium-99m ((99m)Tc)-labeled carbon nanoparticles (T

15 on, for targeting human CRC xenografts using technetium-99m ((99m)Tc)-labeled TCP-1 and fluorescent c

16 r myocardial perfusion imaging of mice using technetium-99m ((99m)Tc)-sestamibi and demonstrate the f

17 imaging and to determine whether dobutamine technetium-99m ((99m)Tc)-sestamibi single-photon emissio

18 labeled with indium-111 ((111)In)-oxine and technetium-99m ((99m)Tc)-Ultratag or (99m)Tc-Ceretec.

19 e kidney MR GFR indices correlated well with technetium 99m (99mTc) diethylenetriaminepentaacetic aci

20 The targeting results of technetium 99m (99mTc)-,iodine 123 (123I)-, and iodine 1

21 In vitro binding assays of technetium 99m (99mTc)-labeled Cy7 tilmanocept were cond

22 affinity for apoptotic cells in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent t

23 3) chelator has been shown to stably complex technetium-99m (99mTc) for nuclear imaging and radiorhen

24 ulty, we have studied a radiopharmaceutical, technetium-99m (99mTc) Infecton, which is based on the a

25 ne (MAG3) forms a single stable chelate with technetium-99m (99mTc) oxotechnetate.

26 ke of thallium-201 (201Tl) at rest with rest technetium-99m (99mTc) sestamibi uptake in the same pati

27 Technetium-99m (99mTc)-labeled leukocytes were quantifie

28 methodology for determining the transport of technetium-99m, a gamma-emitting metastable isomer of (9

29 Technetium-99m activity was monitored with a Nal probe.

30 t peptides (P280 and P748) were labeled with technetium-99m and assessed in a canine thrombosis model

31 tent SSTR-binding peptides were labeled with technetium-99m and assessed in an in vivo study with tum

32 nanobodies were generated, radiolabeled with technetium-99m, and screened in vitro on mouse and human

33 autologous PBMCs were isolated, labeled with technetium-99m, and visualized 3, 4.5, and 6 h post-infu

34 Technetium-99m-antimony trisulfide colloid was the radio

35 hich contain a chelator for the radionuclide technetium-99m are described.

36 hese defects were compared with risk area on technetium-99m autoradiography and infarct size on tissu

37 r short-axis slices of equal thickness using technetium-99m autoradiography and tissue staining, resp

38 mor/nontumor ratios indicate that such small technetium-99m-based molecular probes can be developed a

39 ith human recombinant annexin V labeled with technetium-99m before imaging.

40 Twenty healthy volunteers underwent technetium-99m bicisate SPECT under baseline conditions

41 Technetium-99m-bicisate/SPECT was compared prospectively

42 synthesized for incorporating the well-known technetium-99m-binding hydrazinonicotinamide ligand into

43 ulted in the formation of '3+1' mixed-ligand technetium-99m complexes [TcO(SN(R)S)(SNX(2))] in high r

44 These results suggest that small technetium-99m complexes could be useful as potential me

45 The number of lymph nodes removed, technetium-99m counts for each sentinel lymph node, pres

46 Technetium-99m-DD and 99mTc-LL-EC were excreted more rap

47 Technetium-99m-DD-EC had the highest clearance and extra

48 Technetium-99m-DD-EC has excellent imaging properties an

49 territory caused significant acceleration of technetium-99m diethylenetriamine pentaacetic acid (Tc-9

50 ade it the radiotracer of choice compared to technetium-99m diethylenetriamine pentaacetic acid (Tc-9

51 Simultaneous renal scans (technetium-99m diethylenetriamine pentaacetic acid) of t

52 7-labeled egg and intravenously administered technetium 99m diisopropyl-imino-diacetic acid were imag

53 ratively, and 1 year later, ultrasonography, technetium 99m-dimercaptosuccinic acid (DMSA) scintigrap

54 aphy scans for MIBG-nonavid disease, replace technetium-99m diphosphonate bone scintigraphy for osteo

55 Technetium-99m-disofenin is a suitable label for solidph

56 Technetium-99m-disofenin labeling resulted in in vitro p

57 Technetium-99m-DTPA aerosol clearance measurements can b

58 Technetium-99m-DTPA distributed uniformly without signif

59 Technetium-99m-ECD shows greater contrast than 99mTc-HMP

60 Technetium-99m-ECD SPECT and 18F-FDG PET showed regional

61 xenon-133 in 261 patients and with injected technetium-99m hexamethyl-propyleneamine oxime (HMPAO) i

62 structured psychiatric interview and resting technetium 99m-hexamethyl-propyleneamine oxime single ph

63 ctice CD16 CliniMACS isolation, labeled with technetium 99m-hexamethylpropyleneamine oxime, and then

64 uthors' goal was to evaluate the accuracy of Technetium 99m-HMPAO-labeled leukocyte imaging for scree

65 Technetium-99m-HMPAO and 99mTc-MIBI brain SPECT, MRI, CT

66 Technetium-99m-HMPAO brain SPECT can detect cerebral per

67 Technetium-99m-HMPAO distribution was evaluated in 14 pa

68 Technetium-99m-HMPAO interictal SPECT was performed on t

69 Technetium-99m-HMPAO ROI data also were expressed in uni

70 Technetium-99m-HMPAO was injected intravenously while th

71 Technetium-99m-HSA demonstrated faster washout rates fro

72 Technetium-99m-HSA was supplied commercially.

73 In vivo localization of technetium 99m hydrazinonicotinamide-annexin V was teste

74 Technetium 99m hydroxymethane diphosphonate SPECT/CT bon

75 Radiolabeling with technetium-99m in aqueous media was efficient and gave r

76 inoembryonic antigen (CEA) Fab' labeled with technetium-99m, in the presurgical evaluation of patient

77 and contain a chelator for the radionuclide technetium-99m is described.

78 Technetium-99m-L,L-ethylenedicysteine (99mTc-LL-EC) is a

79 ction of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy.

80 he 41 mice, 6, 6, and 5 received intravenous technetium-99m labeled CRIP for micro-single-photon emis

81 maging of metastatic melanoma has shown that technetium-99m-labeled AADT-(CH2)2-NEt2 (99mTc-1) has th

82 the deposition and clearance of an ultrafine technetium-99m-labeled aerosol in 10 patients with chron

83 Technetium-99m-labeled annexin-V, an endogenous protein

84 tivity in experimental atherosclerosis using technetium-99m-labeled broad matrix metalloproteinase in

85 ocyte accumulation was assessed by uptake of technetium-99m-labeled chemotactic peptide (fMLFK) and c

86 the results of experiments with intravenous technetium-99m-labeled deimmunized antifibrin Fab' fragm

87 Serial technetium-99m-labeled dimercaptosuccinic acid ((99m)Tc-

88 urinary tract infection; renal scanning with technetium-99m-labeled dimercaptosuccinic acid has also

89 hrombi (DVTs) were formed in five dogs, then technetium-99m-labeled Fab' ( approximately 400 mg, appr

90 Technetium-99m-labeled matrix metalloproteinase inhibito

91 computed tomographic imaging, using RP805, a technetium-99m-labeled MMP-specific tracer, followed by

92 hma (FEV1, 76.8 +/- 11.4% predicted) inhaled technetium-99m-labeled monodisperse albuterol aerosols (

93 Technetium-99m-labeled nitroimidazole was administered t

94 Technetium-99m-labeled peptides and monoclonal antibody

95 Technetium-99m-labeled polydiethylenetriamine pentaaceti

96 It was used to synthesize a technetium-99m-labeled salmon calcitonin with the hynic-

97 stress and time control were estimated using technetium-99m labelled autologous red blood cells and g

98 were determined by gamma camera imaging with technetium-99m labelled erythrocytes.

99 Technetium-99m-liposome images showed prominent blood-po

100 Technetium-99m-liposomes, independent of surface modific

101 Technetium-99m-MDP uptake in primary breast carcinoma ha

102 A technetium-99m-mebrofenin scan showed a photopenic area

103 The better quality of images obtained with technetium-99m mercaptoacetyltriglycine (Tc-99m MAG3) ha

104 Technetium-99m-MIBI images, rather than 99mTc-HMPAO brai

105 Technetium-99m-N-NOET bound to RBCs was subsequently ext

106 Technetium-99m-N-NOET has high binding affinity to blood

107 Technetium-99m-N-NOET is a new 99mTc-labeled, neutral ca

108 Technetium-99m-N-NOET myocardial uptake (%ID) was signif

109 Technetium-99m-P483H also outperformed all controls, inc

110 Technetium-99m-P483H associated predominantly with WBCs

111 Technetium-99m-P483H associates predominantly with WBCs

112 Technetium-99m-P483H outperformed 111In-WBCs, 111In-DTPA

113 Technetium-99m-P483H was evaluated for its ability to se

114 Technetium-99m-P483H was incubated with citrated whole h

115 Technetium-99m-P587 and 99mTc-P829 of high-specific acti

116 Technetium-99m-P748 was prepared by either a ligand exch

117 Technetium-99m-P748 was readily prepared at room tempera

118 After intravenous application of 75 MBq of technetium 99m pertechnetate, freehand three-dimensional

119 Within 2 hours of US, technetium-99m pertechnetate was intravenously administe

120 gen (CEA) Fab antibody fragment labeled with technetium-99m-pertechnetate (99mTc), was injected intra

121 In single-center studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imagin

122 Technetium-99m-Q57, 99mTc-Q58 and 99mTc-Q63 are avid tra

123 m, collected via apheresis, and labeled with technetium-99m radioisotope for single-photon emission c

124 mine transporter levels were measured with a technetium-99m radiolabeled analog of cocaine, TRODAT-1,

125 gh specificity of SPECT/CT examination using technetium-99m radiolabeled red blood cells (Tc-99m-RBC)

126 Technetium-99m-red blood cell (RBC) scintigraphy was und

127 m-enhanced inversion-recovery MR imaging and technetium-99m renal cortical scintigraphy.

128 to 58) for a dual-isotope (thallium-201 plus technetium-99m) scan.

129 inologist (S.J.M.), who decided to perform a technetium 99m sestamibi ((99m)Tc MIBI) parathyroid scan

130 y and gamma imaging after a 740-mBq (20-mCi) technetium 99m sestamibi injection.

131 cy compared with that of ultrasonography and technetium 99m sestamibi scanning may be sufficient to a

132 r injection with 25-30 mCi (925-1110 MBq) of technetium 99m sestamibi, patients were imaged with a hi

133 Parathyroid imaging using technetium-99m sestamibi (MIBI) has evolved and can loca

134 rfusion imaging with thallium-201 (n=173) or technetium-99m sestamibi (n=72) and either dipyridamole

135 The technique involved injecting 20 mCi technetium-99m sestamibi 2 hours before surgery and perf

136 s suggest that early perfusion imaging using technetium-99m sestamibi enables reliable risk stratific

137 t ventricular (LV) function from post-stress technetium-99m sestamibi gated SPECT performed >15 min a

138 ts who underwent rest thallium-201/adenosine technetium-99m sestamibi MPS, 254 (4.1%) were lost to fo

139 wall thickening from three-dimensional gated technetium-99m sestamibi myocardial perfusion single-pho

140 assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-pho

141 n fractions can be obtained from gated SPECT technetium-99m sestamibi perfusion images using the imag

142 Same-day rest and dipyridamole technetium-99m sestamibi single photon emission computed

143 cise variables of rest thallium-201/exercise technetium-99m sestamibi single-photon emission computed

144 cardiac magnetic resonance (CMR) imaging or technetium-99m sestamibi single-photon emission computed

145 easurement of infarct size by serum markers, technetium-99m sestamibi single-photon emission computed

146 ribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging.

147 Infarct size, measured by CMR or technetium-99m sestamibi SPECT within 1 month after prim

148 the ability of early perfusion imaging using technetium-99m sestamibi to predict adverse cardiac outc

149 was measured in a subset of 243 patients by technetium-99m sestamibi tomography.

150 Technetium-99m sestamibi uptake after injection at rest

151 Technetium-99m sestamibi uptake was not significantly di

152 Technetium-99m sestamibi was injected 3 min after the co

153 erfusion images using either thallium-201 or technetium-99m sestamibi, and no previous coronary revas

154 was performed on the stress distribution of technetium-99m sestamibi, using eight frames per cardiac

155 est pain underwent MP imaging with SPECT and technetium-99m sestamibi.

156 ommended dose of 740-1100 MBq (20-30 mCi) of technetium 99m-sestamibi is estimated to involve an LAR

157 Technetium-99m-sestamibi activity in the ischemic zone (

158 Technetium-99m-sestamibi appears to indicate the extent

159 Technetium-99m-sestamibi has recently been validated as

160 size with cardiac marker release patterns or technetium-99m-sestamibi single-photon emission computed

161 Technetium-99m-sestamibi was injected intravenously at p

162 and after 300 mL of Ensure was measured with technetium-99m single-photon emission computed tomograph

163 review of studies where either Rb-82 PET or technetium-99m SPECT with both attenuation correction an

164 zation of sentinel lymph nodes with filtered technetium 99m sulfur colloid.

165 technique involved the injection of 4 ml of technetium-99m sulfur colloid (1 mCi [37 MBq]) into the

166 A modified preparation of technetium-99m sulfur colloid with smaller particles tha

167 Technetium-99m-sulfur colloid also forms particles and t

168 SLN mapping requires injection of technetium-99m-sulfur colloid-an effective but sometimes

169 ed tomography (SPECT) after the injection of technetium-99m (Tc-99m) sestamibi at rest.

170 LV) function and infarct size as assessed by technetium-99m (Tc-99m) sestamibi perfusion tomographic

171 e addition of electrocardiographically gated technetium-99m (Tc-99m) sestamibi single-photon emission

172 Technetium-99m (Tc-99m) sestamibi was injected before re

173 rest left ventricular volumes during stress technetium-99m (Tc-99m) sestamibi/rest thallium-201 dual

174 We compared dipyridamole technetium-99m (Tc-99m) tetrofosmin and thallium-201 (Tl

175 clinical use and cost-analysis of acute rest technetium-99m (Tc-99m) tetrofosmin single-photon emissi

176 photon emission computed tomographic (SPECT) technetium-99m (Tc-99m) tracer imaging in patients with

177 r repairs that led to a critical shortage of technetium-99m (Tc-99m).

178 Our objective is to prove that injection of technetium-99m (Tc99) sulfur colloid in a subareolar man

179 Technetium-99m-teboroxime clearance is markedly accelera

180 exercise (44%) or pharmacologic stress (56%) technetium-99m tetrofosmin SPECT.

181 Technetium-99m-tetrofosmin uptake was compared to that o

182 ients with suspected CAD who underwent CCTA, technetium 99m/tetrofosmin-labeled SPECT, and [15O]H2O P

183 Technetium-99m, the most commonly used radionuclide in n

184 Technetium-99m TRODAT-1 is an analog of cocaine that sel

185 od cells (RBCs), labeled with chromium-51 or technetium-99m, were separately coated to equal levels w

186 Complexation of technetium-99m with a mixture of N-R(3-azapentane-1,5-di